Does the dTT1:10 assay provide better monitoring of bivalirudin anticoagulant effect compared to other assay methods in pediatric ECLS?
The dTT1:10 assay is recommended for routine monitoring of bivalirudin in pediatric ECLS due to its reliability and cost-effectiveness.
dTT1:10 appears to be more suitable for routine practice due to fewer variations and lower cost for monitoring bivalirudin in pediatric ECLS.
Teruya et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: